Expression of hepatitis C virus non-structural 5A protein in the liver of transgenic mice

Mainak Majumder, Robert Steele, Asish K. Ghosh, Xiao Yan Zhou, Larry Thornburg, Ranjit Ray, Nancy J. Phillips, Ratna B. Ray

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

Hepatitis C virus (HCV) is a major etiologic agent for chronic hepatitis worldwide often leading to the development of cirrhosis and hepatocellular carcinoma. However, the mechanism for development of chronic hepatitis or hepatocarcinogenesis by HCV remains unclear. HCV NS5A protein possesses many intriguing properties, including sequestration of p53 in the cytoplasm, downregulation of p21 protein, activation of STAT3, and inhibition of tumor necrosis factor-α-mediated apoptosis. Thus, we investigated whether this viral protein has oncogenic property in vivo. In the absence of an efficient cell culture system for virus growth and a suitable small animal model for HCV infection, transgenic FVB mice were generated by targeting the HCV NS5A genomic region cloned under the control of a liver-specific apoE promoter or mouse major urinary promoter (MUP). The apoE promoter is constitutively expressed in liver, on the other hand, the MUP is developmentally regulated and expressed in the liver after birth. Reverse transcription polymerase chain reaction and Western blot analysis indicated establishment of HCV NS5A transgene expression in several lines from both groups of mice. Immunohistochemical studies suggested the presence of NS5A in the cytoplasm of hepatocytes. The transgenic animals were phenotypically similar to their normal littermates and did not exhibit a major histological change within the liver up to 24 months of age. Our results suggested HCV NS5A protein is not directly cytopathic or oncogenic in this FVB transgenic mouse model, although this viral protein promotes cell growth in vitro. These animals will be a valuable model of HCV immunopathology as well as for evaluation of siRNA, interferon and other cytokine therapies.

Original languageEnglish (US)
Pages (from-to)528-532
Number of pages5
JournalFEBS Letters
Volume555
Issue number3
DOIs
StatePublished - Dec 18 2003
Externally publishedYes

Fingerprint

Viruses
Hepacivirus
Liver
Transgenic Mice
Proteins
Animals
Apolipoproteins E
Viral Proteins
Chronic Hepatitis
Animal Hepatitis
Cytoplasm
STAT3 Transcription Factor
Genetically Modified Animals
Virus Diseases
Growth
Polymerase chain reaction
Transgenes
Cell growth
Transcription
Interferons

Keywords

  • Hepatitis C virus
  • Liver specific expression
  • NS5A protein
  • Transgenic mice

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Molecular Biology

Cite this

Majumder, M., Steele, R., Ghosh, A. K., Zhou, X. Y., Thornburg, L., Ray, R., ... Ray, R. B. (2003). Expression of hepatitis C virus non-structural 5A protein in the liver of transgenic mice. FEBS Letters, 555(3), 528-532. https://doi.org/10.1016/S0014-5793(03)01337-1

Expression of hepatitis C virus non-structural 5A protein in the liver of transgenic mice. / Majumder, Mainak; Steele, Robert; Ghosh, Asish K.; Zhou, Xiao Yan; Thornburg, Larry; Ray, Ranjit; Phillips, Nancy J.; Ray, Ratna B.

In: FEBS Letters, Vol. 555, No. 3, 18.12.2003, p. 528-532.

Research output: Contribution to journalArticle

Majumder, M, Steele, R, Ghosh, AK, Zhou, XY, Thornburg, L, Ray, R, Phillips, NJ & Ray, RB 2003, 'Expression of hepatitis C virus non-structural 5A protein in the liver of transgenic mice', FEBS Letters, vol. 555, no. 3, pp. 528-532. https://doi.org/10.1016/S0014-5793(03)01337-1
Majumder M, Steele R, Ghosh AK, Zhou XY, Thornburg L, Ray R et al. Expression of hepatitis C virus non-structural 5A protein in the liver of transgenic mice. FEBS Letters. 2003 Dec 18;555(3):528-532. https://doi.org/10.1016/S0014-5793(03)01337-1
Majumder, Mainak ; Steele, Robert ; Ghosh, Asish K. ; Zhou, Xiao Yan ; Thornburg, Larry ; Ray, Ranjit ; Phillips, Nancy J. ; Ray, Ratna B. / Expression of hepatitis C virus non-structural 5A protein in the liver of transgenic mice. In: FEBS Letters. 2003 ; Vol. 555, No. 3. pp. 528-532.
@article{3a97541457ca4026bbf0661401dca0e5,
title = "Expression of hepatitis C virus non-structural 5A protein in the liver of transgenic mice",
abstract = "Hepatitis C virus (HCV) is a major etiologic agent for chronic hepatitis worldwide often leading to the development of cirrhosis and hepatocellular carcinoma. However, the mechanism for development of chronic hepatitis or hepatocarcinogenesis by HCV remains unclear. HCV NS5A protein possesses many intriguing properties, including sequestration of p53 in the cytoplasm, downregulation of p21 protein, activation of STAT3, and inhibition of tumor necrosis factor-α-mediated apoptosis. Thus, we investigated whether this viral protein has oncogenic property in vivo. In the absence of an efficient cell culture system for virus growth and a suitable small animal model for HCV infection, transgenic FVB mice were generated by targeting the HCV NS5A genomic region cloned under the control of a liver-specific apoE promoter or mouse major urinary promoter (MUP). The apoE promoter is constitutively expressed in liver, on the other hand, the MUP is developmentally regulated and expressed in the liver after birth. Reverse transcription polymerase chain reaction and Western blot analysis indicated establishment of HCV NS5A transgene expression in several lines from both groups of mice. Immunohistochemical studies suggested the presence of NS5A in the cytoplasm of hepatocytes. The transgenic animals were phenotypically similar to their normal littermates and did not exhibit a major histological change within the liver up to 24 months of age. Our results suggested HCV NS5A protein is not directly cytopathic or oncogenic in this FVB transgenic mouse model, although this viral protein promotes cell growth in vitro. These animals will be a valuable model of HCV immunopathology as well as for evaluation of siRNA, interferon and other cytokine therapies.",
keywords = "Hepatitis C virus, Liver specific expression, NS5A protein, Transgenic mice",
author = "Mainak Majumder and Robert Steele and Ghosh, {Asish K.} and Zhou, {Xiao Yan} and Larry Thornburg and Ranjit Ray and Phillips, {Nancy J.} and Ray, {Ratna B.}",
year = "2003",
month = "12",
day = "18",
doi = "10.1016/S0014-5793(03)01337-1",
language = "English (US)",
volume = "555",
pages = "528--532",
journal = "FEBS Letters",
issn = "0014-5793",
publisher = "Elsevier",
number = "3",

}

TY - JOUR

T1 - Expression of hepatitis C virus non-structural 5A protein in the liver of transgenic mice

AU - Majumder, Mainak

AU - Steele, Robert

AU - Ghosh, Asish K.

AU - Zhou, Xiao Yan

AU - Thornburg, Larry

AU - Ray, Ranjit

AU - Phillips, Nancy J.

AU - Ray, Ratna B.

PY - 2003/12/18

Y1 - 2003/12/18

N2 - Hepatitis C virus (HCV) is a major etiologic agent for chronic hepatitis worldwide often leading to the development of cirrhosis and hepatocellular carcinoma. However, the mechanism for development of chronic hepatitis or hepatocarcinogenesis by HCV remains unclear. HCV NS5A protein possesses many intriguing properties, including sequestration of p53 in the cytoplasm, downregulation of p21 protein, activation of STAT3, and inhibition of tumor necrosis factor-α-mediated apoptosis. Thus, we investigated whether this viral protein has oncogenic property in vivo. In the absence of an efficient cell culture system for virus growth and a suitable small animal model for HCV infection, transgenic FVB mice were generated by targeting the HCV NS5A genomic region cloned under the control of a liver-specific apoE promoter or mouse major urinary promoter (MUP). The apoE promoter is constitutively expressed in liver, on the other hand, the MUP is developmentally regulated and expressed in the liver after birth. Reverse transcription polymerase chain reaction and Western blot analysis indicated establishment of HCV NS5A transgene expression in several lines from both groups of mice. Immunohistochemical studies suggested the presence of NS5A in the cytoplasm of hepatocytes. The transgenic animals were phenotypically similar to their normal littermates and did not exhibit a major histological change within the liver up to 24 months of age. Our results suggested HCV NS5A protein is not directly cytopathic or oncogenic in this FVB transgenic mouse model, although this viral protein promotes cell growth in vitro. These animals will be a valuable model of HCV immunopathology as well as for evaluation of siRNA, interferon and other cytokine therapies.

AB - Hepatitis C virus (HCV) is a major etiologic agent for chronic hepatitis worldwide often leading to the development of cirrhosis and hepatocellular carcinoma. However, the mechanism for development of chronic hepatitis or hepatocarcinogenesis by HCV remains unclear. HCV NS5A protein possesses many intriguing properties, including sequestration of p53 in the cytoplasm, downregulation of p21 protein, activation of STAT3, and inhibition of tumor necrosis factor-α-mediated apoptosis. Thus, we investigated whether this viral protein has oncogenic property in vivo. In the absence of an efficient cell culture system for virus growth and a suitable small animal model for HCV infection, transgenic FVB mice were generated by targeting the HCV NS5A genomic region cloned under the control of a liver-specific apoE promoter or mouse major urinary promoter (MUP). The apoE promoter is constitutively expressed in liver, on the other hand, the MUP is developmentally regulated and expressed in the liver after birth. Reverse transcription polymerase chain reaction and Western blot analysis indicated establishment of HCV NS5A transgene expression in several lines from both groups of mice. Immunohistochemical studies suggested the presence of NS5A in the cytoplasm of hepatocytes. The transgenic animals were phenotypically similar to their normal littermates and did not exhibit a major histological change within the liver up to 24 months of age. Our results suggested HCV NS5A protein is not directly cytopathic or oncogenic in this FVB transgenic mouse model, although this viral protein promotes cell growth in vitro. These animals will be a valuable model of HCV immunopathology as well as for evaluation of siRNA, interferon and other cytokine therapies.

KW - Hepatitis C virus

KW - Liver specific expression

KW - NS5A protein

KW - Transgenic mice

UR - http://www.scopus.com/inward/record.url?scp=0347627544&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0347627544&partnerID=8YFLogxK

U2 - 10.1016/S0014-5793(03)01337-1

DO - 10.1016/S0014-5793(03)01337-1

M3 - Article

C2 - 14675768

AN - SCOPUS:0347627544

VL - 555

SP - 528

EP - 532

JO - FEBS Letters

JF - FEBS Letters

SN - 0014-5793

IS - 3

ER -